tiprankstipranks
Advertisement
Advertisement

CH:BMY Stock Latest News

Eikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
The FlyEikon Therapeutics appoints Ching-Pin Chang as chief scientific officer
3d ago
BMY
EIKN
Novartis halts autoimmune CAR-T trials following three deaths, Reuters says
PremiumThe Fly
Novartis halts autoimmune CAR-T trials following three deaths, Reuters says
5d ago
BMY
NVS
Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study
PremiumThe Fly
Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study
6d ago
BMY
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
PremiumThe Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
11d ago
AA
MT
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
PremiumThe Fly
HHS plans to add FDA deputy roles for technology, drugs, CNBC says
12d ago
ABT
BMY
Bristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
PremiumRatingsBristol-Myers Squibb: Late-Stage Pipeline Catalysts Support Buy Rating and Unchanged $80 Price Target
17d ago
BMY
Bristol-Myers Squibb: Sell Rating Reiterated as Competitive Pressures Mount; $40 Price Target Unchanged Signaling Further Downside
Premium
Ratings
Bristol-Myers Squibb: Sell Rating Reiterated as Competitive Pressures Mount; $40 Price Target Unchanged Signaling Further Downside
20d ago
BMY
Atrium Therapeutics earns $15M milestone payment from Bristol Myers
Premium
The Fly
Atrium Therapeutics earns $15M milestone payment from Bristol Myers
20d ago
BMY
RNA
Court revives suit against Bristol Myers over delayed drug, Reuters reports
PremiumThe Fly
Court revives suit against Bristol Myers over delayed drug, Reuters reports
21d ago
BMY
UMBF
Bristol Myers’ first CELMoD myeloma therapy granted accelerated FDA approval
PremiumThe Fly
Bristol Myers’ first CELMoD myeloma therapy granted accelerated FDA approval
21d ago
BMY
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
PremiumRatings
Balanced Risk-Reward Keeps Bristol-Myers Squibb at Hold as Zenbexus CELMoD Opportunity Awaits Key 2026 Data
23d ago
BMY
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
PremiumThe Fly
Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports
25d ago
AZN
BMY
Bristol Myers announces $2.3B campus in Houston, Texas
PremiumThe FlyBristol Myers announces $2.3B campus in Houston, Texas
27d ago
BMY
Midday Fly By: SpaceX slips, Disney reports earnings beat
Premium
The Fly
Midday Fly By: SpaceX slips, Disney reports earnings beat
1M ago
BX
MS
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
Premium
The Fly
Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls
1M ago
AZN
BBY
Bristol Myers upgraded to Buy from Hold at Argus
PremiumThe Fly
Bristol Myers upgraded to Buy from Hold at Argus
1M ago
BMY
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
PremiumThe Fly
Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports
1M ago
AZN
BMY
Schrodinger announces collaboration, software agreement with Bristol Myers
PremiumThe Fly
Schrodinger announces collaboration, software agreement with Bristol Myers
1M ago
BMY
SDGR
AstraZeneca deal talks with Bristol Myers remain active, Semafor says
PremiumThe Fly
AstraZeneca deal talks with Bristol Myers remain active, Semafor says
1M ago
AZN
BMY
TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger
PremiumThe FlyTD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger
1M ago
AZN
BMY
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
Premium
The Fly
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
1M ago
L
TT
Morning Movers: Supernus and Indivior jump following merger pact
Premium
The Fly
Morning Movers: Supernus and Indivior jump following merger pact
1M ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >